Share-Based Payment Transactions (Details) |
12 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
₪ / shares
$ / shares
|
Dec. 31, 2019 |
Jun. 30, 2022
₪ / shares
shares
|
Dec. 31, 2021
₪ / shares
|
May 31, 2020
shares
|
Apr. 28, 2020
₪ / shares
|
May 22, 2019
shares
|
Apr. 04, 2019
shares
|
Jan. 18, 2019
shares
|
Nov. 28, 2013
₪ / shares
shares
|
|
| Share-Based Payment Transactions (Details) [Line Items] | |||||||||||
| Granted excess years | 10 years | ||||||||||
| Shares issued (in Shares) | 30 | 30 | |||||||||
| Par value (in New Shekels per share) | ₪ / shares | ₪ 0.25 | ₪ 0.25 | ₪ 0.25 | ₪ 0.25 | ₪ 25 | ||||||
| Number of ordinary shares (in Shares) | 25,000,000 | ||||||||||
| Future shares (in Shares) | 6,618,500 | ||||||||||
| Weighted average remaining contractual life | 8 years 5 months 12 days | 6 years 11 months 23 days | 7 years 11 months 4 days | ||||||||
| Weighted average grant date fair value (in Dollars per share) | $ / shares | $ 0.18 | ₪ 0.16 | |||||||||
| Compensation costs not yet recognized (in Dollars) | $ | $ 1,139 | ||||||||||
| Weighted average period | 2 years 9 months 25 days | ||||||||||
| Ordinary Shares [Member] | |||||||||||
| Share-Based Payment Transactions (Details) [Line Items] | |||||||||||
| Shares issued (in Shares) | 45,000,000 | 492,308 | 223,810 | 2,500,000 | |||||||
| X | ||||||||||
- Definition Future shares. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|